Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33

Virology

Volumn 283, Issue 2, 2001, Pages 353-357

  Fligge, Claudia ^a   Giroglou, Tzenan ^a   Streeck, Rolf E ^a   Sapp, Martin ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Capsomeres; Dose r esponse; Neutralization; Papillomavirus; Vaccination

Indexed keywords

ANTISERUM; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CAPSOMERE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN PAPILLOMAVIRUS TYPE 33; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS CAPSID; VIRUS GENE; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 33; MIRIDAE; PAPILLOMAVIRUS;

EID: 0035837058     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0875     Document Type: Article

References (23)

1. Structures of bovine and human papillomaviruses: Analysis by cryoelectron microscopy and three-dimensional image reconstruction
2. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
3. Immunization with virus-like particles from cottonrail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
4. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies
5. Human papillomavirus infection requires cell surface heparan sulfate
6. Immunological analyses of human papillomavirus capsids
7. Three-dimensional structure of vaccinia virus-produced human papiflomavirus type 1 capsids
8. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
9. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae
10. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
11. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype
12. Expression of human papillomavirus type 11 L1 protein in insect cells: In vivo and in vitro assembly of virus-like particles
13. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies from human sera
14. Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies
15. Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines
16. Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein
17. Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles
18. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe
19. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas
20. Generation and neutralization of pseudovirions of human papillomavirus type 33
21. Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells
22. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles
23. Human papillomaviruses